Lipocalin-2 as a therapeutic target for brain injury: An astrocentric perspective

Progress in Neurobiology

Volumn 144, Issue , 2016, Pages 158-172

  Suk, Kyoungho ^a  

^a Kyungpook National University School of Medicine   (South Korea)

Author keywords

Astrocyte; Biomarker; Brain injury; Drug target; Glia; Ischemia; Lipocalin 2; microRNA; Neuroinflammation; Stroke

Indexed keywords

GLIOCALIN; IRON BINDING PROTEIN; MICRORNA; NEUTROPHIL GELATINASE ASSOCIATED LIPOCALIN; UNCLASSIFIED DRUG;

ASTROCYTE; BRAIN HEMORRHAGE; BRAIN INJURY; BRAIN ISCHEMIA; CELL ACTIVATION; CEREBROVASCULAR ACCIDENT; DRUG TARGETING; GENE EXPRESSION REGULATION; GENETIC TRANSCRIPTION; HUMAN; NERVE CELL; NERVOUS SYSTEM INFLAMMATION; NONHUMAN; PRIORITY JOURNAL; PROTEIN PROCESSING; PROTEIN SECRETION; PROTEIN TARGETING; REVIEW; TRANSLATIONAL RESEARCH; ANIMAL; BRAIN INJURIES; DRUG EFFECTS; METABOLISM;

ANIMALS; ASTROCYTES; BRAIN INJURIES; HUMANS; LIPOCALIN-2;

EID: 84989858464     PISSN: 03010082     EISSN: 18735118     Source Type: Journal    
DOI: 10.1016/j.pneurobio.2016.08.001     Document Type: Review

References (104)

1. Abella, V., Scotece, M., Conde, J., Gomez, R., Lois, A., Pino, J., Gomez-Reino, J.J., Lago, F., Mobasheri, A., Gualillo, O., The potential of lipocalin-2/NGAL as biomarker for inflammatory and metabolic diseases. Biomarkers 20 (2015), 565–571.
2. Almeida-Suhett, C.P., Li, Z., Marini, A.M., Braga, M.F., Eiden, L.E., Temporal course of changes in gene expression suggests a cytokine-related mechanism for long-term hippocampal alteration after controlled cortical impact. J. Neurotrauma 31 (2014), 683–690.
3. Anwaar, I., Gottsater, A., Ohlsson, K., Mattiasson, I., Lindgarde, F., Increasing levels of leukocyte-derived inflammatory mediators in plasma and cAMP in platelets during follow-up after acute cerebral ischemia. Cerebrovasc. Dis. 8 (1998), 310–317.
4. Araque, A., Carmignoto, G., Haydon, P.G., Oliet, S.H., Robitaille, R., Volterra, A., Gliotransmitters travel in time and space. Neuron 81 (2014), 728–739.
5. Asimakopoulou, A., Borkham-Kamphorst, E., Tacke, F., Weiskirchen, R., Lipocalin-2 (NGAL/LCN2), a help-me signal in organ inflammation. Hepatology 63 (2016), 669–671.
6. Beppu, K., Sasaki, T., Tanaka, K.F., Yamanaka, A., Fukazawa, Y., Shigemoto, R., Matsui, K., Optogenetic countering of glial acidosis suppresses glial glutamate release and ischemic brain damage. Neuron 81 (2014), 314–320.
7. Berard, J.L., Zarruk, J.G., Arbour, N., Prat, A., Yong, V.W., Jacques, F.H., Akira, S., David, S., Lipocalin 2 is a novel immune mediator of experimental autoimmune encephalomyelitis pathogenesis and is modulated in multiple sclerosis. Glia 60 (2012), 1145–1159.
8. Borregaard, N., Sorensen, O.E., Theilgaard-Monch, K., Neutrophil granules: a library of innate immunity proteins. Trends Immunol. 28 (2007), 340–345.
9. Cabedo Martinez, A.I., Weinhaupl, K., Lee, W.K., Wolff, N.A., Storch, B., Zerko, S., Konrat, R., Kozminski, W., Breuker, K., Thevenod, F., Coudevylle, N., Biochemical and structural characterization of the interaction between the siderocalin NGAL/LCN2 and the N-terminal domain of its endocytic receptor SLC22A17. J. Biol. Chem. 291 (2016), 2917–2930.
10. Chan, C.P., Jiang, H.L., Leung, L.Y., Wan, W.M., Cheng, N.M., Ip, W.S., Cheung, K.Y., Chan, R.W., Wong, L.K., Graham, C.A., Renneberg, R., Rainer, T.H., Multiple atherosclerosis-related biomarkers associated with short- and long-term mortality after stroke. Clin. Biochem. 45 (2012), 1308–1315.
11. Chan, J.L., Reeves, T.M., Phillips, L.L., Osteopontin expression in acute immune response mediates hippocampal synaptogenesis and adaptive outcome following cortical brain injury. Exp. Neurol. 261 (2014), 757–771.
12. Chaudhry, R., Madden-Fuentes, R.J., Ortiz, T.K., Balsara, Z., Tang, Y., Nseyo, U., Wiener, J.S., Ross, S.S., Seed, P.C., Inflammatory response to Escherichia coli urinary tract infection in the neurogenic bladder of the spinal cord injured host. J. Urol. 191 (2014), 1454–1461.
13. Cherry, J.D., Olschowka, J.A., O'Banion, M.K., Neuroinflammation and M2 microglia: the good, the bad, and the inflamed. J. Neuroinflammation, 11, 2014, 98.
14. Chia, W.J., Dawe, G.S., Ong, W.Y., Expression and localization of the iron-siderophore binding protein lipocalin 2 in the normal rat brain and after kainate-induced excitotoxicity. Neurochem. Int. 59 (2011), 591–599.
15. Chia, W.J., Tan, F.C., Ong, W.Y., Dawe, G.S., Expression and localisation of brain-type organic cation transporter (BOCT) in the hippocampus after kainate-induced excitotoxicity. Neurochem. Int. 87 (2015), 43–59.
16. Choi, J., Lee, H.W., Suk, K., Increased plasma levels of lipocalin 2 in mild cognitive impairment. J. Neurol. Sci. 305 (2011), 28–33.
17. Choudhury, G.R., Ding, S., Reactive astrocytes and therapeutic potential in focal ischemic stroke. Neurobiol. Dis. 85 (2015), 234–244.
18. Choy, Y.J., Hong, S.Y., Pack, S.J., Woo, R.S., Baik, T.K., Song, D.Y., Changes of gene expression of Gal3, Hsp27, Lcn2, and Timp1 in rat substantia nigra following medial forebrain bundle transection using a candidate gene microarray. J. Chem. Neuroanat. 66–67 (2015), 10–18.
19. Chun, B.Y., Kim, J.H., Nam, Y., Huh, M.I., Han, S., Suk, K., Pathological involvement of astrocyte-derived lipocalin-2 in the demyelinating optic neuritis. Invest. Ophthalmol. Vis. Sci. 56 (2015), 3691–3698.
20. David, S., Kroner, A., Repertoire of microglial and macrophage responses after spinal cord injury. Nat. Rev. Neurosci. 12 (2011), 388–399.
21. Di Somma, S., Zampini, G., Vetrone, F., Soto-Ruiz, K.M., Magrini, L., Cardelli, P., Ronco, C., Maisel, A., Peacock, F.W., Opinion paper on utility of point-of-care biomarkers in the emergency department pathways decision making. Clin. Chem. Lab. Med. 52 (2014), 1401–1407.
22. Dong, M., Xi, G., Keep, R.F., Hua, Y., Role of iron in brain lipocalin 2 upregulation after intracerebral hemorrhage in rats. Brain Res. 1505 (2013), 86–92.
23. Egashira, Y., Hua, Y., Keep, R.F., Xi, G., Acute white matter injury after experimental subarachnoid hemorrhage: potential role of lipocalin 2. Stroke 45 (2014), 2141–2143.
24. Elneihoum, A.M., Falke, P., Axelsson, L., Lundberg, E., Lindgarde, F., Ohlsson, K., Leukocyte activation detected by increased plasma levels of inflammatory mediators in patients with ischemic cerebrovascular diseases. Stroke 27 (1996), 1734–1738.
25. Falke, P., Elneihoum, A.M., Ohlsson, K., Leukocyte activation: relation to cardiovascular mortality after cerebrovascular ischemia. Cerebrovasc. Dis. 10 (2000), 97–101.
26. Fernandez-Cadenas, I., Del Rio-Espinola, A., Domingues-Montanari, S., Mendioroz, M., Fernandez-Morales, J., Penalba, A., Rubiera, M., Hernandez-Guillamon, M., Rosell, A., Delgado, P., Chacon, P., Ribo, M., Alvarez-Sabin, J., Molina, C.A., Garcia-Arumi, E., Montaner, J., Genes involved in hemorrhagic transformations that follow recombinant t-PA treatment in stroke patients. Pharmacogenomics 14 (2013), 495–504.
27. Ferreira, A.C., Da Mesquita, S., Sousa, J.C., Correia-Neves, M., Sousa, N., Palha, J.A., Marques, F., From the periphery to the brain: lipocalin-2, a friend or foe?. Prog. Neurobiol. 131 (2015), 120–136.
28. Flower, D.R., North, A.C., Sansom, C.E., The lipocalin protein family: structural and sequence overview. Biochim Biophys. Acta 1482 (2000), 9–24.
29. Flower, D.R., The lipocalin protein family: structure and function. Biochem. J. 318:Pt. 1 (1996), 1–14.
30. Ganfornina, M.D., Gutierrez, G., Bastiani, M., Sanchez, D., A phylogenetic analysis of the lipocalin protein family. Mol. Biol. Evol. 17 (2000), 114–126.
31. Ghosh, M., Sodhi, S.S., Kim, J.H., Kim, N.E., Mongre, R.K., Sharma, N., Kim, S.W., Oh, S.J., Pulicherla, K.K., Jeong, D.K., An integrated In silico approach for the structural and functional exploration of lipocalin 2 and its functional insights with metalloproteinase 9 and lipoprotein receptor-related protein 2. Appl. Biochem. Biotechnol. 176 (2015), 712–729.
32. Goetz, D.H., Holmes, M.A., Borregaard, N., Bluhm, M.E., Raymond, K.N., Strong, R.K., The neutrophil lipocalin NGAL is a bacteriostatic agent that interferes with siderophore-mediated iron acquisition. Mol. Cell 10 (2002), 1033–1043.
33. Gordon, S., Alternative activation of macrophages. Nat. Rev. Immunol. 3 (2003), 23–35.
34. Gourine, A.V., Kasymov, V., Marina, N., Tang, F., Figueiredo, M.F., Lane, S., Teschemacher, A.G., Spyer, K.M., Deisseroth, K., Kasparov, S., Astrocytes control breathing through pH-dependent release of ATP. Science 329 (2010), 571–575.
35. Gradinaru, V., Mogri, M., Thompson, K.R., Henderson, J.M., Deisseroth, K., Optical deconstruction of parkinsonian neural circuitry. Science 324 (2009), 354–359.
36. Hamzic, N., Blomqvist, A., Nilsberth, C., Immune-induced expression of lipocalin-2 in brain endothelial cells: relationship with interleukin-6, cyclooxygenase-2 and the febrile response. J. Neuroendocrinol. 25 (2013), 271–280.
37. Hawlisch, H., Wills-Karp, M., Karp, C.L., Kohl, J., The anaphylatoxins bridge innate and adaptive immune responses in allergic asthma. Mol. Immunol. 41 (2004), 123–131.
38. Herrmann, J.E., Imura, T., Song, B., Qi, J., Ao, Y., Nguyen, T.K., Korsak, R.A., Takeda, K., Akira, S., Sofroniew, M.V., STAT3 is a critical regulator of astrogliosis and scar formation after spinal cord injury. J. Neurosci. 28 (2008), 7231–7243.
39. Hoffmann, A., Conradt, H.S., Gross, G., Nimtz, M., Lottspeich, F., Wurster, U., Purification and chemical characterization of beta-trace protein from human cerebrospinal fluid: its identification as prostaglandin D synthase. J. Neurochem. 61 (1993), 451–456.
40. Hu, X., Leak, R.K., Shi, Y., Suenaga, J., Gao, Y., Zheng, P., Chen, J., Microglial and macrophage polarization-new prospects for brain repair. Nat. Rev. Neurol. 11 (2015), 56–64.
41. Ip, J.P., Nocon, A.L., Hofer, M.J., Lim, S.L., Muller, M., Campbell, I.L., Lipocalin 2 in the central nervous system host response to systemic lipopolysaccharide administration. J. Neuroinflammation, 8, 2011, 124.
42. Jang, E., Kim, J.H., Lee, S., Seo, J.W., Jin, M., Lee, M.G., Jang, I.S., Lee, W.H., Suk, K., Phenotypic polarization of activated astrocytes: the critical role of lipocalin-2 in the classical inflammatory activation of astrocytes. J. Immunol. 191 (2013), 5204–5219.
43. Jang, E., Lee, S., Kim, J.H., Seo, J.W., Lee, W.H., Mori, K., Nakao, K., Suk, K., Secreted protein lipocalin-2 promotes microglial M1 polarization. FASEB J. 27 (2013), 1176–1190.
44. Jeon, S., Jha, M.K., Ock, J., Seo, J., Jin, M., Cho, H., Lee, W.H., Suk, K., Role of lipocalin-2-chemokine axis in the development of neuropathic pain following peripheral nerve injury. J. Biol. Chem. 288 (2013), 24116–24127.
45. Jha, M.K., Jeon, S., Jin, M., Lee, W.H., Suk, K., Acute phase protein lipocalin-2 is associated with formalin-induced nociception and pathological pain. Immune Netw. 13 (2013), 289–294.
46. Jha, M.K., Jeon, S., Jin, M., Ock, J., Kim, J.H., Lee, W.H., Suk, K., The pivotal role played by lipocalin-2 in chronic inflammatory pain. Exp. Neurol. 254 (2014), 41–53.
47. Jha, M.K., Lee, S., Park, D.H., Kook, H., Park, K.G., Lee, I.K., Suk, K., Diverse functional roles of lipocalin-2 in the central nervous system. Neurosci. Biobehav. Rev. 49 (2015), 135–156.
48. Ji, Z.G., Wang, H., Optogenetic control of astrocytes: is it possible to treat astrocyte-related epilepsy?. Brain Res. Bull. 110 (2015), 20–25.
49. Jin, M., Jang, E., Suk, K., Lipocalin-2 acts as a neuroinflammatogen in lipopolysaccharide-injected mice. Exp. Neurobiol. 23 (2014), 155–162.
50. Jin, M., Kim, J.H., Jang, E., Lee, Y.M., Soo Han, H., Woo, D.K., Park, D.H., Kook, H., Suk, K., Lipocalin-2 deficiency attenuates neuroinflammation and brain injury after transient middle cerebral artery occlusion in mice. J. Cereb. Blood Flow Metab. 34 (2014), 1306–1314.
51. Kehrer, J.P., Lipocalin-2: pro- or anti-apoptotic?. Cell Biol. Toxicol. 26 (2010), 83–89.
52. Kjeldsen, L., Bainton, D.F., Sengelov, H., Borregaard, N., Structural and functional heterogeneity among peroxidase-negative granules in human neutrophils: identification of a distinct gelatinase-containing granule subset by combined immunocytochemistry and subcellular fractionation. Blood 82 (1993), 3183–3191.
53. Kjeldsen, L., Bainton, D.F., Sengelov, H., Borregaard, N., Identification of neutrophil gelatinase-associated lipocalin as a novel matrix protein of specific granules in human neutrophils. Blood 83 (1994), 799–807.
54. Kjeldsen, L., Cowland, J.B., Borregaard, N., Human neutrophil gelatinase-associated lipocalin and homologous proteins in rat and mouse. Biochim. Biophys. Acta 1482 (2000), 272–283.
55. Kohl, J., Self, non-self, and danger: a complementary view. Adv. Exp. Med. Biol 586 (2006), 71–94.
56. Korn, T., Mitsdoerffer, M., Croxford, A.L., Awasthi, A., Dardalhon, V.A., Galileos, G., Vollmar, P., Stritesky, G.L., Kaplan, M.H., Waisman, A., Kuchroo, V.K., Oukka, M., IL-6 controls Th17 immunity in vivo by inhibiting the conversion of conventional T cells into Foxp3+ regulatory T cells. Proc. Natl. Acad. Sci. U. S. A 105 (2008), 18460–18465.
57. Larsen, M.T., Hager, M., Glenthoj, A., Asmar, F., Clemmensen, S.N., Mora-Jensen, H., Borregaard, N., Cowland, J.B., miRNA-130a regulates C/EBP-epsilon expression during granulopoiesis. Blood 123 (2014), 1079–1089.
58. Lee, S., Lee, J., Kim, S., Park, J.Y., Lee, W.H., Mori, K., Kim, S.H., Kim, I.K., Suk, K., A dual role of lipocalin 2 in the apoptosis and deramification of activated microglia. J. Immunol. 179 (2007), 3231–3241.
59. Lee, S., Park, J.Y., Lee, W.H., Kim, H., Park, H.C., Mori, K., Suk, K., Lipocalin-2 is an autocrine mediator of reactive astrocytosis. J. Neurosci. 29 (2009), 234–249.
60. Lee, S., Kim, J.H., Seo, J.W., Han, H.S., Lee, W.H., Mori, K., Nakao, K., Barasch, J., Suk, K., Lipocalin-2 Is a chemokine inducer in the central nervous system: role of chemokine ligand 10 (CXCL10) in lipocalin-2-induced cell migration. J. Biol. Chem. 286 (2011), 43855–43870.
61. Lee, S., Jang, E., Kim, J.H., Lee, W.H., Suk, K., Lipocalin-type prostaglandin D2 synthase protein regulates glial cell migration and morphology through myristoylated alanine-rich C-kinase substrate: prostaglandin D2-independent effects. J. Biol. Chem. 287 (2012), 9414–9428.
62. Lee, K.A., Ahn, J.Y., Lee, S.H., Singh Sekhon, S., Kim, D.G., Min, J., Kim, Y.H., Aptamer-based sandwich assay and its clinical outlooks for detecting lipocalin-2 in hepatocellular carcinoma (HCC). Sci. Rep., 5, 2015, 10897.
63. Lee, S., Jha, M.K., Suk, K., Lipocalin-2 in the inflammatory activation of brain astrocytes. Crit. Rev. Immunol. 35 (2015), 77–84.
64. Listwak, S.J., Rathore, P., Herkenham, M., Minimal NF-kappaB activity in neurons. Neuroscience 250 (2013), 282–299.
65. Liu, Z., Petersen, R., Devireddy, L., Impaired neutrophil function in 24p3 null mice contributes to enhanced susceptibility to bacterial infections. J. Immunol. 190 (2013), 4692–4706.
66. Luchtefeld, M., Preuss, C., Ruhle, F., Bogalle, E.P., Sietmann, A., Figura, S., Muller, W., Grote, K., Schieffer, B., Stoll, M., Gp130-dependent release of acute phase proteins is linked to the activation of innate immune signaling pathways. PLoS One, 6, 2011, e19427.
67. Marques, F., Mesquita, S.D., Sousa, J.C., Coppola, G., Gao, F., Geschwind, D.H., Columba-Cabezas, S., Aloisi, F., Degn, M., Cerqueira, J.J., Sousa, N., Correia-Neves, M., Palha, J.A., Lipocalin 2 is present in the EAE brain and is modulated by natalizumab. Front. Cell. Neurosci., 6, 2012, 33.
68. Mesquita, S.D., Ferreira, A.C., Falcao, A.M., Sousa, J.C., Oliveira, T.G., Correia-Neves, M., Sousa, N., Marques, F., Palha, J.A., Lipocalin 2 modulates the cellular response to amyloid beta. Cell Death Differ. 21 (2014), 1588–1599.
69. Mishra, J., Ma, Q., Prada, A., Mitsnefes, M., Zahedi, K., Yang, J., Barasch, J., Devarajan, P., Identification of neutrophil gelatinase-associated lipocalin as a novel early urinary biomarker for ischemic renal injury. J. Am. Soc. Nephrol. 14 (2003), 2534–2543.
70. Mucha, M., Skrzypiec, A.E., Schiavon, E., Attwood, B.K., Kucerova, E., Pawlak, R., Lipocalin-2 controls neuronal excitability and anxiety by regulating dendritic spine formation and maturation. Proc. Natl. Acad. Sci. U. S. A. 108 (2011), 18436–18441.
71. Nagata, A., Suzuki, Y., Igarashi, M., Eguchi, N., Toh, H., Urade, Y., Hayaishi, O., Human brain prostaglandin D synthase has been evolutionarily differentiated from lipophilic-ligand carrier proteins. Proc. Natl. Acad. Sci. U. S. A. 88 (1991), 4020–4024.
72. Nam, Y., Kim, J.H., Seo, M., Jin, M., Jeon, S., Seo, J.W., Lee, W.H., Bing, S.J., Jee, Y., Lee, W.K., Park, D.H., Kook, H., Suk, K., Lipocalin-2 protein deficiency ameliorates experimental autoimmune encephalomyelitis: the pathogenic role of lipocalin-2 in the central nervous system and peripheral lymphoid tissues. J. Biol. Chem. 289 (2014), 16773–16789.
73. Nataf, S., Carroll, S.L., Wetsel, R.A., Szalai, A.J., Barnum, S.R., Attenuation of experimental autoimmune demyelination in complement-deficient mice. J. Immunol. 165 (2000), 5867–5873.
74. Naude, P.J., Nyakas, C., Eiden, L.E., Ait-Ali, D., van der Heide, R., Engelborghs, S., Luiten, P.G., De Deyn, P.P., den Boer, J.A., Eisel, U.L., Lipocalin 2: novel component of proinflammatory signaling in Alzheimer's disease. FASEB J. 26 (2012), 2811–2823.
75. Ni, W., Zheng, M., Xi, G., Keep, R.F., Hua, Y., Role of lipocalin-2 in brain injury after intracerebral hemorrhage. J. Cereb. Blood Flow Metab. 35 (2015), 1454–1461.
76. Nocon, A.L., Ip, J.P., Terry, R., Lim, S.L., Getts, D.R., Muller, M., Hofer, M.J., King, N.J., Campbell, I.L., The bacteriostatic protein lipocalin 2 is induced in the central nervous system of mice with west Nile virus encephalitis. J. Virol. 88 (2014), 679–689.
77. Okada, S., Nakamura, M., Katoh, H., Miyao, T., Shimazaki, T., Ishii, K., Yamane, J., Yoshimura, A., Iwamoto, Y., Toyama, Y., Okano, H.1, Conditional ablation of Stat3 or Socs3 discloses a dual role for reactive astrocytes after spinal cord injury. Nat. Med. 12 (2006), 829–834.
78. Perez-Alvarez, A., Araque, A., Astrocyte-neuron interaction at tripartite synapses. Curr. Drug Targets 14 (2013), 1220–1224.
79. Poh, K.W., Yeo, J.F., Stohler, C.S., Ong, W.Y., Comprehensive gene expression profiling in the prefrontal cortex links immune activation and neutrophil infiltration to antinociception. J. Neurosci. 32 (2012), 35–45.
80. Prinz, M., Priller, J., Microglia and brain macrophages in the molecular age: from origin to neuropsychiatric disease. Nat. Rev. Neurosci. 15 (2014), 300–312.
81. Rathore, K.I., Berard, J.L., Redensek, A., Chierzi, S., Lopez-Vales, R., Santos, M., Akira, S., David, S., Lipocalin 2 plays an immunomodulatory role and has detrimental effects after spinal cord injury. J. Neurosci. 31 (2011), 13412–13419.
82. Rodvold, J.J., Mahadevan, N.R., Zanetti, M., Lipocalin 2 in cancer: when good immunity goes bad. Cancer Lett. 316 (2012), 132–138.
83. Rudd, P.M., Mattu, T.S., Masure, S., Bratt, T., Van den Steen, P.E., Wormald, M.R., Kuster, B., Harvey, D.J., Borregaard, N., Van Damme, J., Dwek, R.A., Opdenakker, G., Glycosylation of natural human neutrophil gelatinase B and neutrophil gelatinase B-associated lipocalin. Biochemistry 38 (1999), 13937–13950.
84. Sasaki, T., Beppu, K., Tanaka, K.F., Fukazawa, Y., Shigemoto, R., Matsui, K., Application of an optogenetic byway for perturbing neuronal activity via glial photostimulation. Proc. Natl. Acad. Sci. U. S. A. 109 (2012), 20720–20725.
85. Shiratori-Hayashi, M., Koga, K., Tozaki-Saitoh, H., Kohro, Y., Toyonaga, H., Yamaguchi, C., Hasegawa, A., Nakahara, T., Hachisuka, J., Akira, S., Okano, H., Furue, M., Inoue, K., Tsuda, M., STAT3-dependent reactive astrogliosis in the spinal dorsal horn underlies chronic itch. Nat. Med. 21 (2015), 927–931.
86. Sickinger, S., Maier, H., Konig, S., Vallant, N., Kofler, M., Schumpp, P., Schwelberger, H., Hermann, M., Obrist, P., Schneeberger, S., Margreiter, R., Troppmair, J., Pratschke, J., Aigner, F., Lipocalin-2 as mediator of chemokine expression and granulocyte infiltration during ischemia and reperfusion. Transplant. Int. 26 (2013), 761–769.
87. Song, E., Fan, P., Huang, B., Deng, H.B., Cheung, B.M., Feletou, M., Vilaine, J.P., Villeneuve, N., Xu, A., Vanhoutte, P.M., Wang, Y., Deamidated lipocalin-2 induces endothelial dysfunction and hypertension in dietary obese mice. J. Am. Heart Assoc., 3, 2014, e000837.
88. Sriram, K., Benkovic, S.A., Hebert, M.A., Miller, D.B., O'Callaghan, J.P., Induction of gp130-related cytokines and activation of JAK2/STAT3 pathway in astrocytes precedes up-regulation of glial fibrillary acidic protein in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine model of neurodegeneration key signaling pathway for astrogliosis in vivo?. J. Biol. Chem. 279 (2004), 19936–19947.
89. Stankiewicz, A.M., Goscik, J., Majewska, A., Swiergiel, A.H., Juszczak, G.R., The effect of acute and chronic social stress on the hippocampal transcriptome in mice. PLoS One, 10, 2015, e0142195.
90. Szalai, A.J., Hu, X., Adams, J.E., Barnum, S.R., Complement in experimental autoimmune encephalomyelitis revisited: C3 is required for development of maximal disease. Mol. Immunol. 44 (2007), 3132–3136.
91. Tarassishin, L., Loudig, O., Bauman, A., Shafit-Zagardo, B., Suh, H.S., Lee, S.C., Interferon regulatory factor 3 inhibits astrocyte inflammatory gene expression through suppression of the proinflammatory miR-155 and miR-155. Glia 59 (2011), 1911–1922.
92. Tarassishin, L., Suh, H.S., Lee, S.C., Interferon regulatory factor 3 plays an anti-inflammatory role in microglia by activating the PI3 K/Akt pathway. J. Neuroinflammation, 8, 2011, 187.
93. Teschemacher, A.G., Gourine, A.V., Kasparov, S., A role for astrocytes in sensing the brain microenvironment and neuro-metabolic integration. Neurochem. Res. 40 (2015), 2386–2393.
94. Tong, J., Huang, C., Bi, F., Wu, Q., Huang, B., Liu, X., Li, F., Zhou, H., Xia, X.G., Expression of ALS-linked TDP-43 mutant in astrocytes causes non-cell-autonomous motor neuron death in rats. EMBO J. 32 (2013), 1917–1926.
95. Urade, Y., Hayaishi, O., Biochemical, structural, genetic, physiological, and pathophysiological features of lipocalin-type prostaglandin D synthase. Biochim. Biophys. Acta 1482 (2000), 259–271.
96. Wang, G., Weng, Y.C., Han, X., Whaley, J.D., McCrae, K.R., Chou, W.H., Lipocalin-2 released in response to cerebral ischaemia mediates reperfusion injury in mice. J. Cell. Mol. Med. 19 (2015), 1637–1645.
97. Watanabe, K., Urade, Y., Mader, M., Murphy, C., Hayaishi, O., Identification of beta-trace as prostaglandin D synthase. Biochem. Biophys. Res. Commun. 203 (1994), 1110–1116.
98. Weng, Y.C., Wang, G., Messing, R.O., Chou, W.H., Identification of lipocalin-2 as a PKCdelta phosphorylation substrate in neutrophils. J. Biomed. Sci., 22, 2015, 21.
99. Wu, B., Li, C., Du, Z., Yao, Q., Wu, J., Feng, L., Zhang, P., Li, S., Xu, L., Li, E., Network based analyses of gene expression profile of LCN2 overexpression in esophageal squamous cell carcinoma. Sci. Rep., 4, 2014, 5403.
100. Wu, L., Du, Y., Lok, J., Lo, E.H., Xing, C., Lipocalin-2 enhances angiogenesis in rat brain endothelial cells via reactive oxygen species and iron-dependent mechanisms. J. Neurochem. 132 (2015), 622–628.
101. Xing, C., Wang, X., Cheng, C., Montaner, J., Mandeville, E., Leung, W., van Leyen, K., Lok, J., Lo, E.H., Neuronal production of lipocalin-2 as a help-me signal for glial activation. Stroke 45 (2014), 2085–2092.
102. Xiong, H., Luo, T., He, W., Xi, D., Lu, H., Li, M., Liu, J., Guo, Z., Up-regulation of miR-138 inhibits hypoxia-induced cardiomyocyte apoptosis via down-regulating lipocalin-2 expression. Exp. Biol. Med. (Maywood) 41 (2016), 25–30.
103. Zamanian, J.L., Xu, L., Foo, L.C., Nouri, N., Zhou, L., Giffard, R.G., Barres, B.A., Genomic analysis of reactive astrogliosis. J. Neurosci. 32 (2012), 6391–6410.
104. Zhai, L., Wang, T., Kang, K., Zhao, Y., Shrotriya, P., Nilsen-Hamilton, M., An RNA aptamer-based microcantilever sensor to detect the inflammatory marker, mouse lipocalin-2. Anal. Chem. 84 (2012), 8763–8770.